Norges Bank’s Verve Therapeutics VERV Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-78,186	Closed	-$441K	–	1623
2024 Q4	$441K	Buy	+78,186	New	+$441K	﹤0.01%	1800
2024 Q3	–	Sell	-78,186	Closed	-$382K	–	1698
2024 Q2	$382K	Buy	+78,186	New	+$382K	﹤0.01%	1893